Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Multi-modal proteomic characterization of lysosomal function and proteostasis in progranulin-deficient neurons

Journal article

WADE-MARTINS R., (2023), Molecular Neurodegeneration, 18

Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson's disease models.

Journal article

Williamson MG. et al, (2023), Hum Mol Genet

Impaired dopamine release in Parkinson’s disease

Journal article

Cramb KML. et al, (2023), Brain

Identification of a possible proteomic Biomarker in Parkinson’s Disease: Discovery and Replication in Blood, brain and CSF

Journal article

WINCHESTER L. and NEVADO-HOLGADO A., (2022), Brain Communications

Inhibition of the SUV4-20 H1 histone methyltransferase increases frataxin expression in Friedreich's ataxia patient cells.

Journal article

Vilema-Enríquez G. et al, (2020), J Biol Chem, 295, 17973 - 17985

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease

Journal article

BENGOA-VERGNIORY N. et al, (2020), Nature Communications

Load More